KeyBanc raised the firm’s price target on ICU Medical (ICUI) to $209 from $198 on higher multiple, while keeping an Overweight rating on the shares. The firm was broadly encouraged by a continuation of improved underlying momentum, and views the initial details around its IV Solutions JV agreement favorably.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.